{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:49:19Z","timestamp":1765828159823,"version":"3.48.0"},"reference-count":52,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,4,28]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      People of Ashkenazi Jewish (AJ) ancestry are more likely than unselected populations to have a\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      pathogenic variant, which cause a significantly increased risk of breast, ovarian and prostate cancer. Three specific\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      pathogenic variants, referred to as\n                      <jats:italic>BRCA<\/jats:italic>\n                      -Jewish founder mutations (B-JFM), account for &gt;90% of\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      pathogenic variants in people of AJ ancestry. Current practice of identifying eligible individuals for\n                      <jats:italic>BRCA<\/jats:italic>\n                      testing based on personal and\/or family history has been shown to miss at least 50% of people who have one of these variants. Here we describe the protocol of the JeneScreen study\u2014a study established to develop and evaluate two different population-based B-JFM screening programmes, offered to people of Jewish ancestry in Sydney and Melbourne, Australia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>To rmeasure the acceptability of population-based B-JFM screening in Australia, two screening programmes using different methodologies have been developed. The Sydney JeneScreen programme provides information and obtains informed consent by way of an online tool. The Melbourne JeneScreen programme does this by way of community sessions attended in person. Participants complete questionnaires to measure clinical and psychosocial outcomes at baseline, and for those who have testing, 2\u2009weeks postresult. Participants who decline testing are sent a questionnaire regarding reasons for declining. Participants with a B-JFM are sent questionnaires 12-month and 24-month post-testing. The questionnaires incorporate validated scales, which measure anxiety, decisional conflict and regret, and test-related distress and positive experiences, and other items specifically developed or adapted for the study. These measures will be assessed for each programme and the two population-based B-JFM screening methods will be compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Institutional Human Research Ethics Committee approval was obtained from the South Eastern Area Health Service Human Research Ethics Committee: HREC Ref 16\/125.Following the analysis of the study results, the findings will be disseminated widely through conferences and publications, and directly to participants in writing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-041186","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T12:35:50Z","timestamp":1624624550000},"page":"e041186","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of two population screening programmes for\n                    <i>BRCA1\/2<\/i>\n                    founder mutations in the Australian Jewish community: a protocol paper"],"prefix":"10.1136","volume":"11","author":[{"given":"Nicole E","family":"Cousens","sequence":"first","affiliation":[{"name":"Hereditary Cancer Centre, Prince of Wales Hospital Cancer Services, Randwick, New South Wales, Australia"},{"name":"UNSW Prince of Wales Clinical School, Randwick, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-6632","authenticated-orcid":false,"given":"Jane","family":"Tiller","sequence":"additional","affiliation":[{"name":"Victorian Clinical Genetics Services Ltd, Parkville, Victoria, Australia"},{"name":"Murdoch Childrens Research Institute, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Meiser","sequence":"additional","affiliation":[{"name":"UNSW Prince of Wales Clinical School, Randwick, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Barlow-Stewart","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Rowley","sequence":"additional","affiliation":[{"name":"Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-An","family":"Ko","sequence":"additional","affiliation":[{"name":"Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakshi","family":"Mahale","sequence":"additional","affiliation":[{"name":"Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian G","family":"Campbell","sequence":"additional","affiliation":[{"name":"Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajneesh","family":"Kaur","sequence":"additional","affiliation":[{"name":"Medical Education Office, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Bankier","sequence":"additional","affiliation":[{"name":"The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Burnett","sequence":"additional","affiliation":[{"name":"Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Jacobs","sequence":"additional","affiliation":[{"name":"University of Technology Sydney, Ultimo, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A","family":"James","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia"},{"name":"Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Trainer","sequence":"additional","affiliation":[{"name":"Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Parkville, Victoria, Australia"},{"name":"Department of Medicine, University of Melbourne, Melbourne, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Neil","sequence":"additional","affiliation":[{"name":"Epworth Hospital, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin B","family":"Delatycki","sequence":"additional","affiliation":[{"name":"Victorian Clinical Genetics Services Ltd, Parkville, Victoria, Australia"},{"name":"Bruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Andrews","sequence":"additional","affiliation":[{"name":"Hereditary Cancer Centre, Prince of Wales Hospital Cancer Services, Randwick, New South Wales, Australia"},{"name":"UNSW Prince of Wales Clinical School, Randwick, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"2025121511402011000_11.6.e041186.1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010715)92:2<440::AID-CNCR1340>3.0.CO;2-O"},{"key":"2025121511402011000_11.6.e041186.2","doi-asserted-by":"publisher","DOI":"10.1086\/302320"},{"key":"2025121511402011000_11.6.e041186.3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R"},{"key":"2025121511402011000_11.6.e041186.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.8133"},{"key":"2025121511402011000_11.6.e041186.5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.14.1241"},{"key":"2025121511402011000_11.6.e041186.6","doi-asserted-by":"publisher","DOI":"10.1086\/302853"},{"key":"2025121511402011000_11.6.e041186.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7112"},{"key":"2025121511402011000_11.6.e041186.8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm203"},{"key":"2025121511402011000_11.6.e041186.9","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.383"},{"key":"2025121511402011000_11.6.e041186.10","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.146"},{"key":"2025121511402011000_11.6.e041186.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.5985"},{"key":"2025121511402011000_11.6.e041186.12","unstructured":"eviQ . Genetic testing for heritable mutations: BRCA1 and BRCA2 genes. eviQ cancer treatments online 2019."},{"key":"2025121511402011000_11.6.e041186.13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3747\/co.22.2527","article-title":"Is it time to offer BRCA1 and BRCA2 testing to all Jewish women?","volume":"22","author":"Metcalfe","year":"2015","journal-title":"Curr Oncol"},{"key":"2025121511402011000_11.6.e041186.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.0712"},{"key":"2025121511402011000_11.6.e041186.15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jnci\/dju379","article-title":"Population testing for cancer predisposing BRCA1\/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial","volume":"107","author":"Manchanda","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2025121511402011000_11.6.e041186.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1415979111"},{"key":"2025121511402011000_11.6.e041186.17","unstructured":"Census data 2016. In: Statistics ABo, editor 2017."},{"key":"2025121511402011000_11.6.e041186.18","unstructured":"Graham D , Narunsky L . The Jewish population of Australia: key findings from the 2016 census. Australian Centre for the Study of Jewish Civilisation, Monash University, 2019."},{"key":"2025121511402011000_11.6.e041186.19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju380"},{"key":"2025121511402011000_11.6.e041186.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1941-0"},{"key":"2025121511402011000_11.6.e041186.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2010.01499.x"},{"key":"2025121511402011000_11.6.e041186.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.12483"},{"key":"2025121511402011000_11.6.e041186.23","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju420","article-title":"Precision medicine meets public health: population screening for BRCA1 and BRCA2","volume":"107","author":"Levy-Lahad","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2025121511402011000_11.6.e041186.24","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181b765d3"},{"key":"2025121511402011000_11.6.e041186.25","doi-asserted-by":"publisher","DOI":"10.1089\/10906570152742245"},{"key":"2025121511402011000_11.6.e041186.26","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.278"},{"key":"2025121511402011000_11.6.e041186.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra013182"},{"key":"2025121511402011000_11.6.e041186.28","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.050112"},{"key":"2025121511402011000_11.6.e041186.29","unstructured":"Wilson JMG , Jugner G . Principles and practice of screening for disease. Geneva: World Health Organization, 1968."},{"key":"2025121511402011000_11.6.e041186.30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.8626"},{"key":"2025121511402011000_11.6.e041186.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1237"},{"key":"2025121511402011000_11.6.e041186.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2016.06.010"},{"key":"2025121511402011000_11.6.e041186.33","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.309"},{"key":"2025121511402011000_11.6.e041186.34","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.4.e45"},{"key":"2025121511402011000_11.6.e041186.35","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2003.00074.x"},{"key":"2025121511402011000_11.6.e041186.36","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.11010"},{"key":"2025121511402011000_11.6.e041186.37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5694\/j.1326-5377.1995.tb124595.x","article-title":"The Tay-Sachs disease prevention program in Australia: Sydney pilot study","volume":"163","author":"Burnett","year":"1995","journal-title":"Med J Aust"},{"key":"2025121511402011000_11.6.e041186.38","doi-asserted-by":"crossref","unstructured":"Cousens N , Kaur R , Meiser B , et al . Community attitudes towards a Jewish community BRCA1\/2 testing program. Familial Cancer 2016:1\u201312.","DOI":"10.1007\/s10689-016-9918-0"},{"key":"2025121511402011000_11.6.e041186.39","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.067850"},{"key":"2025121511402011000_11.6.e041186.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63012-7"},{"key":"2025121511402011000_11.6.e041186.41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ejhg.2011.247","article-title":"ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasible","volume":"20","author":"Delatycki","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"2025121511402011000_11.6.e041186.42","unstructured":"Vanderbilt . RedCap (research electronic data capture) 2018."},{"key":"2025121511402011000_11.6.e041186.43","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-320","article-title":"How should we discuss genetic testing with women newly diagnosed with breast cancer? design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer","volume":"12","author":"Watts","year":"2012","journal-title":"BMC Cancer"},{"key":"2025121511402011000_11.6.e041186.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2004.02.007"},{"key":"2025121511402011000_11.6.e041186.45","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/GIM.0b013e3182217a19","article-title":"Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling?","volume":"13","author":"Zilliacus","year":"2011","journal-title":"Genet Med"},{"key":"2025121511402011000_11.6.e041186.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1992.tb00997.x"},{"key":"2025121511402011000_11.6.e041186.47","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9501500105"},{"key":"2025121511402011000_11.6.e041186.48","unstructured":"O\"Connor AM . User manual- decisional conflict scale, 1993."},{"key":"2025121511402011000_11.6.e041186.49","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X03256005"},{"key":"2025121511402011000_11.6.e041186.50","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.21.6.564"},{"key":"2025121511402011000_11.6.e041186.51","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181993175"},{"key":"2025121511402011000_11.6.e041186.52","doi-asserted-by":"crossref","unstructured":"Cohen J . Statistical power analysis for the behavioral sciences. Academic press, 2013.","DOI":"10.4324\/9780203771587"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-041186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:40:30Z","timestamp":1765827630000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-041186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,25]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/bmjopen-2020-041186"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-041186","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}